FDA panel recommends COVID-19 boosters only for those 65 and older or at high risk

US FDA: No Pfizer booster shots for 16 and above, approved only for people over 65

Washington

Bay Area residents want their COVID boosters soon, but defer to FDA experts

When an FDA advisory panel agreed Friday that only those 65 and older or otherwise at high risk of severe COVID-19 should get vaccine booster shots to bolster their immunity, Colleen Logan found herself left out of that equation.The 60-year-old Walnut Creek kindergarten teacher worries that working with kids too young for the shots puts her at risk of the deadly disease. She hoped she’d qualify soon after President Biden last month announced pla…

Oregon ready to administer vaccine booster shots if approved, health authority says

A federal advisory panel has recommended Pfizer booster shots, but only for people 65 or older, or those who run a high risk of severe illness from COVID-19.The boosters would come at least six months after a person receives their second Pfizer dose.Communicable disease supervisor Jill Johnson draws out doses of the Pfizer-BioNTech COVID-19 vaccine at the Deschutes County Public Health Department in Bend, Ore., Tuesday, Jan. 12, 2021. (Bradley W…

F.D.A. Panel Rejects Biden’s Push for Universal COVID-19 Booster Shots

Expert advisers said the Pfizer boosters should be available for people older than 65 and for those at risk of severe illness.

FDA Panel Voted 16–2 To Deny Authorization of Pfizer’s COVID Vaccine “Booster” Shot to the General Public

The key scientific advisory council of the Food and Drug Administration has voted to deny authorization of a “booster” shot of Pfizer’s mRNA vaccine to...The post FDA Panel Voted 16–2 To Deny Authorization of Pfizer’s COVID Vaccine “Booster” Shot to the General Public appeared first on SciTechDaily.

Video: Here's why Boston doctor agrees with limiting Pfizer COVID boosters

An FDA advisory panel voted 16-2 to reject the White House's plan to deliver boosters to everyone this fall and unanimously chose to limit those shots to people who are 65 and older or at high risk of severe disease.